Pierre Lafolie MD, PhD Senior Consultant, Clinical
Download
Report
Transcript Pierre Lafolie MD, PhD Senior Consultant, Clinical
Pierre Lafolie MD, PhD
Senior Consultant, Clinical Pharmacology, Karolinska University Hospital – Solna, Stockholm
Senior Reader, Associate professor, Dep of Medicine - Solna, Karolinska Institutet, Stockholm
Scientific Secretary, Research Ethical Review Board, Stockholm
Luleå
Sites marked * are University hospitals
Umeå *
Falun and Borlänge
Stockholm* and Uppsala*
Linköping* and Örebro*
Göteborg*
Kalmar
Malmö* and Lund*
Phase-1 unit
Need for authorisation by Competent Authority
Sometimes connected to a specific therapeutic area
Emergency Care Unit needed near-by
Specific therapeutic field
Connected to a clinic
Eg. oncology, orthopedic, dementia, pediatric …
General
Often connected to a phase-1 unit when located at a hospital
Open Care Trial Unit
No beds needed
Clinics/Hospital departments
Clinical research centers
S3 Clinical Research Centers, Stockholm
Blekinge kompetenscentrum, Karlskrona
Centrum för klinisk forskning Västmanland,
Västerås
Centrum för klinisk prövning, Sahlgrenska
Universitetssjukhuset, Göteborg
Clinical Research Support, Örebro
Forskningsenheten, Ersta Sjukhus, Stockholm
Gothia Forum, Sahlgrenska
Universitetssjukhuset, Göteborg
Karolinska Trial Alliance, Stockholms Läns
Landsting, Stockholm
Kliniskt forskningscentrum, Norrlands
Universitetssjukhus, Umeå
LARC, Universitetsjukhuset Linköping,
Linköping
Region Skånes Kompetenscentrum för Klinisk
forskning, Skånes Universitetssjukhus, Lund
SLL Innovation, Stockholms Läns Landsting,
Danderyd
Smärtspecialistmottagningen, Stockholm
Uppsala Clinical Research Centre,
Akademiska Sjukhuset , Uppsala
FoU-enheten, Norrbottens Läns Landsting, Luleå
FoU-enheten, Karolinska Universitetssjukhuset,
Stockholm
Gastrocentrum, Karolinska Universitetssjukhuset,
Stockholm
Hjärtkliniken, Karolinska Universitetssjukhuset,
Stockholm
Infektionskliniken, Karolinska Universitetssjukhuset,
Stockholm
Instutitionen för klinisk neurovetenskap, Karolinska
Institutet , Stockholm
Kardiologkliniken, Falu Lasarett, Falun
Kliniken för Endokrinologi, Karolinska
Universitetssjukhuset, Stockholm
Kliniken för Plastikkirurgi, Karolinska
Universitetssjukhuset, Stockholm
Klinisk Farmakologi, Karolinska Universitetssjukhuset,
Stockholm
Klinisk Farmakologisk Prövningsenhet, Karolinska
Universitetssjukhuset, Stockholm
KPE Onkologiska Kliniken, Radiumhemmet, Karolinska
Universitetssjukhuset, Stockholm
Kvinnokliniken, Karolinska Universitetssjukhuset,
Stockholm
Medicintekniskt centrum Novum, Karolinska
Universitetssjukhuset,Stockholm
Neurologiska kliniken, Akademiska Sjukhuset, Uppsala
Onkologiskt Centrum, Lunds Universitetssjukhus
Ortopedkliniken, Länssjukhuset i Kalmar, Kalmar
Reumatologiska kliniken, Sahlgrenska
Universitetssjukhuset, Göteborg
Transplantationskirurgi, Karolinska
Universitetssjukhuset, Stockholm
Baseline
SOPs
Adequate premises with relevant equipment
Relevant professions
Competent staff with expertise and up-dated training including
GCP
Social and financial skill
Extra
Outstanding portfolio, preferably publiced
Documented agency inspections
Documented audits
Drug trials
New chemical entities, new indications, orphan drugs
Medical Devices
Mostly in class 1B, 2A and 2B
Nutrition
Medical nutrition, food additive’s
One dedicated CTU in the country
Advise
SME’s and young researchers often need a general CTU to discuss
protocol, statistics and ”how-to-do-it”
Feasibility
How many patients are available
How many will participate
How to approach them
Time to approval
CA, Ethics, and other (eg. radiation committee), amendments
Hospital resources
Availability of doctors,nurses and technical staff
Eg. probability to have an endpoint x-ray in dedicated time window
No referals
Project ”forgotten” by collegues?
Do drugs, nutrition and medical devices
All phases 1-4
Have some smaller funding to support academic’s
Is expected to meet its own cost
Organised as
company owned by the university or the hospital
an in-house department
Baseline staff backed up with consultants
Focused on attracting studies (income)
Is also contracting partner for all other commercial studies at
the hospital
One-stop-shop
Have established prices for services and algorithms for
preparing bids
Have an established financial system for transparency of
incoming payments
- How are commercial clinical research financed
in your country?
State assistance? Only by industry?
Are there staff made available for commercial
clinical trials in hospitals?
What type: CRT, clinical research
nurses, investigators?
Do they receive trainings?
Who finance these professionals?
Are investigators certified to practise clinical
research in your country?
Is there a PCB training frame of reference?
What is the process for hospital contracts
signature?
A unique contract for all the implicated centers
or a center per center contract?
- Do industry sponsors have
performance criteria provided in
order to measure their commercial
clinical trials?
- At a national level, at a centers
scale ?
- How is feasibility done?
- Process in the centers,
response time?
- Are privileged partnership between
industry sponsors and investigation
centers/hospitals possible?
- Are there clinical investigation
networks connecting hospitals and
doctor offices (outside of hospitals) in
your country?
- How are they organised?
[email protected]